HEALTH
Sanofi to Sell Winthrop for $450 Million: The drug, cosmetics and perfume unit of French oil group Elf Aquitaine said it will sell nearly all of Sterling Winthrop’s diagnostic imaging business to Norway’s Hafslund Nycomed for $450 million. The sale follows Sanofi’s agreement last week to acquire Sterling Winthrop, the prescription pharmaceutical business of Rochester, N.Y.-based Eastman Kodak, for $1.675 billion. At the time, Sanofi said it would sell Sterling Winthrop activities it considered non-strategic, for about $500 million. Sanofi said in a statement that diagnostic imaging, which involves the production and sale of contrast agents used in radiology by hospitals, clinics and radiologists, is not the sort of business it wants to engage in.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.